PCV1- A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN AS PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH ESTABLISHED PERIPHERAL ARTERY DISEASE

Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-75.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71234-7/fulltext
Title : PCV1- A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN AS PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH ESTABLISHED PERIPHERAL ARTERY DISEASE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71234-7&doi=10.1046/j.1524-4733.2001.40202-75.x
First page :
Section Title :
Open access? : No
Section Order : 126
Categories :
Tags :
Regions :
ViH Article Tags :